15-deoxy-delta-12,14-PGJ2

15-deoxy-delta-12,14-pgj2 is a lipid of Fatty Acyls (FA) class. 15-deoxy-delta-12,14-pgj2 is associated with abnormalities such as Dehydration and Myocardial Ischemia. The involved functions are known as Binding (Molecular Function), Inflammation, Alveolar ventilation function, Stimulus and Process. 15-deoxy-delta-12,14-pgj2 often locates in Cytosol, Myocardial tissue and Heart tissue. The associated genes with 15-deoxy-delta-12,14-PGJ2 are Homologous Gene and G-substrate. The related lipids are 15-deoxyprostaglandin J2 and Lipopolysaccharides.

Cross Reference

Introduction

To understand associated biological information of 15-deoxy-delta-12,14-PGJ2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 15-deoxy-delta-12,14-PGJ2?

15-deoxy-delta-12,14-PGJ2 is suspected in Dehydration, Myocardial Ischemia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 15-deoxy-delta-12,14-PGJ2

MeSH term MeSH ID Detail
Actinobacillus Infections D000189 4 associated lipids
Arteriosclerosis D001161 86 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Body Weight D001835 333 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Brain Ischemia D002545 89 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Fibrosis D005355 23 associated lipids
Goiter D006042 4 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hyperalgesia D006930 42 associated lipids
Inflammation D007249 119 associated lipids
Insulin Resistance D007333 99 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Lung Neoplasms D008175 171 associated lipids
Myocardial Infarction D009203 21 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 | Total 30

PubChem Associated disorders and diseases

What pathways are associated with 15-deoxy-delta-12,14-PGJ2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 15-deoxy-delta-12,14-PGJ2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 15-deoxy-delta-12,14-PGJ2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 15-deoxy-delta-12,14-PGJ2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 15-deoxy-delta-12,14-PGJ2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 15-deoxy-delta-12,14-PGJ2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 15-deoxy-delta-12,14-PGJ2

Download all related citations
Per page 10 20 50 100 | Total 940
Authors Title Published Journal PubMed Link
Pignatelli M et al. The peroxisome proliferator-activated receptor gamma is an inhibitor of ErbBs activity in human breast cancer cells. 2001 J. Cell. Sci. pmid:11739643
Takeda K et al. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. 2001 J. Biol. Chem. pmid:11687581
Thévenon C et al. Gas chromatographic-mass spectrometric measurement of 15-deoxy-delta(12,14)-prostaglandin J(2), the peroxisome proliferator-activated receptor gamma ligand, in urine. 2001 Clin. Chem. pmid:11274037
Rohn TT et al. 15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis. 2001 Neuroreport pmid:11277593
Wilmer WA et al. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma. 2001 Biochem. Biophys. Res. Commun. pmid:11178960
Kitamura Y et al. Effects of 15-deoxy-delta(12,14) prostaglandin J(2) and interleukin-4 in Toll-like receptor-4-mutant glial cells. 2001 Eur. J. Pharmacol. pmid:11164379
Garcia Palacios V et al. Expression of adipogenesis markers in a murine stromal cell line treated with 15-deoxy Delta(12,14)-prostaglandin J2, interleukin-11, 9-cis retinoic acid and vitamin K2. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11728175
Levine L Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11728177
Boyault S et al. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways. 2001 FEBS Lett. pmid:11457450
Marx N et al. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. 2000 J. Immunol. pmid:10843708
Rossi A et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. 2000 Nature pmid:10638762
Clark RB et al. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. 2000 J. Immunol. pmid:10640751
Galli A et al. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. 2000 Hepatology pmid:10613734
Padilla J et al. PPAR-gamma-mediated regulation of normal and malignant B lineage cells. 2000 Ann. N. Y. Acad. Sci. pmid:10818446
Goetze S et al. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells. 2000 J. Cardiovasc. Pharmacol. pmid:10813377
Padilla J et al. Effects of 15-deoxy-delta 12,14-PGJ2 on B lineage cells. 2000 Ann. N. Y. Acad. Sci. pmid:10818475
Inoue H et al. Feedback control of cyclooxygenase-2 expression through PPARgamma. 2000 J. Biol. Chem. pmid:10827178
Fain JN et al. Regulation of leptin release by troglitazone in human adipose tissue. 2000 Metab. Clin. Exp. pmid:11092516
Straus DS et al. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10781090
Wächtershäuser A et al. PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate. 2000 Biochem. Biophys. Res. Commun. pmid:10833422
Taba Y et al. Fluid shear stress induces lipocalin-type prostaglandin D(2) synthase expression in vascular endothelial cells. 2000 Circ. Res. pmid:10807869
Shirahase H et al. Inhibitory effects of PGD2, PGJ2 and 15-deoxy-delta12,14-PGJ2 on iNOS induction in rat mesenteric artery. 2000 Life Sci. pmid:10834301
Koppal T et al. Cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells. 2000 Brain Res. pmid:10837804
Asano T et al. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation. 2000 Biochim. Biophys. Acta pmid:10838168
Viergutz T et al. Relationship between different stages of the corpus luteum and the expression of the peroxisome proliferator-activated receptor gamma protein in bovine large lutein cells. 2000 J. Reprod. Fertil. pmid:10793637
Rubin GL et al. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. 2000 Cancer Res. pmid:10749129
Tsubouchi Y et al. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. 2000 Biochem. Biophys. Res. Commun. pmid:10753637
Kawamoto Y et al. Cyclopentenone prostaglandins as potential inducers of phase II detoxification enzymes. 15-deoxy-delta(12,14)-prostaglandin j2-induced expression of glutathione S-transferases. 2000 J. Biol. Chem. pmid:10753940
Kasai K et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) facilitates thyroglobulin production by cultured human thyrocytes. 2000 Am. J. Physiol., Cell Physiol. pmid:11078701
Faveeuw C et al. Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells. 2000 FEBS Lett. pmid:11119715
Padilla J et al. Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells. 2000 J. Immunol. pmid:11120820
Hortelano S et al. Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages. 2000 J. Immunol. pmid:11086094
Miyahara T et al. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. 2000 J. Biol. Chem. pmid:10969082
Vanaja DK et al. Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-delta12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells. 2000 Cancer Res. pmid:10987274
Bernardo A et al. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. 2000 Eur. J. Neurosci. pmid:10947800
Maxey KM et al. The nature and composition of 15-deoxy-Delta(12,14)PGJ(2). 2000 Prostaglandins Other Lipid Mediat. pmid:10936412
Clay CE et al. 15-deoxy-Delta(12,14)PGJ(2) induces diverse biological responses via PPARgamma activation in cancer cells. 2000 Prostaglandins Other Lipid Mediat. pmid:10936413
Heneka MT et al. Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. 2000 J. Neurosci. pmid:10995830
Miwa Y et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces G(1) arrest and differentiation marker expression in vascular smooth muscle cells. 2000 Mol. Pharmacol. pmid:10999955
Kawahito Y et al. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. 2000 J. Clin. Invest. pmid:10903334
Chattopadhyay N et al. Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis. 2000 J. Neurosci. Res. pmid:10861801
Paik JH et al. Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase. Mediation through different signaling pathways. 2000 J. Biol. Chem. pmid:10866999
Maggi LB et al. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. 2000 Diabetes pmid:10868955
Marra F et al. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. 2000 Gastroenterology pmid:10930382
Bamba H et al. Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells. 2000 Biochem. Biophys. Res. Commun. pmid:10873632
Ikeda U et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells. 2000 Hypertension pmid:10856269
Sugiyama H et al. Peroxisome proliferator-activated receptors are expressed in mouse bone marrow-derived mast cells. 2000 FEBS Lett. pmid:10675550
Castrillo A et al. Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages. 2000 Mol. Cell. Biol. pmid:10669746
Butler R et al. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2. 2000 Cell Growth Differ. pmid:10672903
Takeda K et al. Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells. 2000 Circulation pmid:11023940